Assignee profile

Biotheryx

Coverage of patents, compounds and activity records linked to this assignee.

3 patents253 compounds174 activity records
Summary
AssigneeBiotheryx
Filing years2017-2020
Patents3
Compounds253
Activity records174
Patent families3
Targets6
Assay familiescellular_function, degradation, unknown
Activity metricsdegradation, inhibition
Overview

Target distribution and active-compound trend

Target distribution

771 activity records

7 targets

Active compounds by publication year

Distinct compounds linked to assignee patent publications

08216320182023
Activity compounds and values

Activity records

771 records
Structure
Control
Value
ConcentrationTime
Record IDCompoundAssayDetails
2D structure for PGDB_C004432
% Inhibition->=80%----MOLM-13US20200369679A1PGDB_A007024PGDB_C004432PGDB_AS001386View
2D structure for PGDB_C004534
% Inhibition-<25%----MOLM-13US20200369679A1PGDB_A008100PGDB_C004534PGDB_AS001386View
2D structure for PGDB_C004472
% Inhibition-<25%----MOLM-13US20200369679A1PGDB_A008109PGDB_C004472PGDB_AS001386View
2D structure for PGDB_C004551
% Inhibition->=80%----MOLM-13US20200369679A1PGDB_A008136PGDB_C004551PGDB_AS001386View
2D structure for PGDB_C004507
% Inhibition-<25%----MOLM-13US20200369679A1PGDB_A008372PGDB_C004507PGDB_AS001386View
2D structure for PGDB_C004528
% Inhibition-<25%----MOLM-13US20200369679A1PGDB_A008580PGDB_C004528PGDB_AS001386View
2D structure for PGDB_C004564
% Inhibition-<25%----MOLM-13US20200369679A1PGDB_A008940PGDB_C004564PGDB_AS001386View
2D structure for PGDB_C004436
% Inhibition-=25-50%-----US20200369679A1PGDB_A009129PGDB_C004436PGDB_AS000773View
2D structure for PGDB_C004455
% Inhibition-<25%----MOLM-13US20200369679A1PGDB_A009377PGDB_C004455PGDB_AS001386View
2D structure for PGDB_C004522
% Inhibition-<25%----MOLM-13US20200369679A1PGDB_A009662PGDB_C004522PGDB_AS001386View
2D structure for PGDB_C004484
% Inhibition-<25%----MOLM-13US20200369679A1PGDB_A010163PGDB_C004484PGDB_AS001386View
2D structure for PGDB_C004512
% Inhibition-<25%----MOLM-13US20200369679A1PGDB_A010192PGDB_C004512PGDB_AS001386View
2D structure for PGDB_C004433
% Inhibition->=80%----MOLM-13US20200369679A1PGDB_A010690PGDB_C004433PGDB_AS001386View
2D structure for PGDB_C004447
% Inhibition-<25%----MOLM-13US20200369679A1PGDB_A011113PGDB_C004447PGDB_AS001386View
2D structure for PGDB_C004515
% Inhibition->=80%----MOLM-13US20200369679A1PGDB_A011129PGDB_C004515PGDB_AS001386View
2D structure for PGDB_C004478
% Inhibition->=80%----MOLM-13US20200369679A1PGDB_A011647PGDB_C004478PGDB_AS001386View
2D structure for PGDB_C004432
% Degradation->=80%--IKZF1--US20200369679A1PGDB_A011888PGDB_C004432PGDB_AS002410View
2D structure for PGDB_C004492
% Inhibition-<25%----MOLM-13US20200369679A1PGDB_A012321PGDB_C004492PGDB_AS001386View
2D structure for PGDB_C004523
% Inhibition-<25%----MOLM-13US20200369679A1PGDB_A012880PGDB_C004523PGDB_AS001386View
2D structure for PGDB_C004489
% Inhibition->=80%----MOLM-13US20200369679A1PGDB_A012917PGDB_C004489PGDB_AS001386View
Page 1 of 39 · 771 records